First experience of a hemophilia monitoring platform: florio HAEMO
- PMID: 35308098
- PMCID: PMC8918679
- DOI: 10.1002/rth2.12685
First experience of a hemophilia monitoring platform: florio HAEMO
Abstract
Background: florio HAEMO is a new hemophilia treatment monitoring application consisting of a patient smartphone application (app) and a web-based dashboard for healthcare professionals, providing several novel features, including activity tracking, wearable connectivity, kids and caregiver mode, and real-time pharmacokinetic factor level estimation.
Objectives: To assess intuitiveness, ease-of-use, and patient preference of florio HAEMO in Central Europe using a cross-sectional survey.
Methods: This survey was conducted in six Central European countries between 9 December 2020 and 24 May 2021. The online questionnaire included 17 questions about overall satisfaction, ease-of-use, intuitiveness, and patient preference. Adults or children with hemophilia on regular prophylaxis and using the florio HAEMO app for a minimum of 1 week were invited to complete the online questionnaire by their treating physician.
Results: Sixty-six participants took part in the survey. The median duration for all respondents using the florio HAEMO app was 3 to 4 weeks. Overall, 89.4% of users reported being very satisfied or rather satisfied after using florio HAEMO. Of the 23 respondents who had switched from another hemophilia app, 87.0% indicated that they strongly preferred or preferred using florio HAEMO. Most florio HAEMO users reported that the app was very easy or rather easy to use (97.0%) and intuitive (94.0%). florio HAEMO had a positive impact on daily living, with 78.8% of users reporting that the app was very important or rather important to them.
Conclusions: This survey suggests that florio HAEMO is an easy-to-use and intuitive app to assist self-management of home prophylaxis.
Keywords: hemophilia; patient preference; pharmacokinetics; telemedicine.
© 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).
Figures
References
-
- Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia. Haemophilia. 2020;26(S6):1‐158. - PubMed
-
- Walker I, Sigouin C, Sek J, et al. Comparing hand‐held computers and paper diaries for haemophilia home therapy: a randomized trial. Haemophilia. 2004;10(6):698‐704. - PubMed
-
- Mondorf W, Siegmund B, Mahnel R, et al. Haemoassist™– a hand‐held electronic patient diary for haemophilia home care. Haemophilia. 2009;15(2):464‐472. - PubMed
-
- Tiede A, Bonanad S, Santamaria A, et al. Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: systematic assessments from an electronic diary. Haemophilia. 2020;26(6):999‐1008. - PubMed
-
- Hay CRM, Xiang H, Scott M, et al. The haemtrack home therapy reporting system: design, implementation, strengths and weaknesses: a report from UK Haemophilia Centre Doctors Organisation. Haemophilia. 2017;23(5):728‐735. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
